| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 9, Issue 6 451-464, Copyright © 1998 by American Association of Cancer Research
ARTICLES |
JA Schroeder and DC Lee
Department of Microbiology and Immunology, University of North Carolina School of Medicine, Chapel Hill 27599-7295, USA.
The complex system of ERBB receptors and ligands is implicated in growth and differentiation of the mammary gland. However, it has not been comprehensively examined in this dynamic tissue. Combined RNA and protein analyses of glands in different stages from virgin to involution revealed differential expression of the four ERBB receptors, as well as distinctive patterns of ERBB ligand expression that suggested specialized function. ERBB localization was linked to mammary gland function. Thus, in the virgin gland, ERBB1 and ERBB2 were colocalized to all major cell types during ductal morphogenesis but differentially localized in the mature gland. All four ERBB receptors were restricted to epithelia in the differentiated gland. Analyses of ERBB tyrosine phosphorylation provided strong evidence of interaction between the four receptors in this physiological context. Thus, exogenous EGF induced stage-dependent transphosphorylation of ERBB2-4 as well as ERBB1, whereas endogenous phosphorylation of all four receptors peaked in late pregnancy and lactation.
This article has been cited by other articles:
![]() |
R. S. Muraoka-Cook, M. A. Sandahl, K. E. Strunk, L. C. Miraglia, C. Husted, D. M. Hunter, K. Elenius, L. A. Chodosh, and H. S. Earp III ErbB4 Splice Variants Cyt1 and Cyt2 Differ by 16 Amino Acids and Exert Opposing Effects on the Mammary Epithelium In Vivo Mol. Cell. Biol., September 15, 2009; 29(18): 4935 - 4948. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. N. Blance, A. H. Sims, E. Anderson, A. Howell, and R. B. Clarke Normal Breast Tissue Implanted into Athymic Nude Mice Identifies Biomarkers of the Effects of Human Pregnancy Levels of Estrogen Cancer Prevention Research, March 1, 2009; 2(3): 257 - 264. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Muraoka-Cook, M. Sandahl, D. Hunter, L. Miraglia, and H. S. Earp III Prolactin and ErbB4/HER4 Signaling Interact via Janus Kinase 2 to Induce Mammary Epithelial Cell Gene Expression Differentiation Mol. Endocrinol., October 1, 2008; 22(10): 2307 - 2321. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Golipour, D. Myers, T. Seagroves, D. Murphy, G. I. Evan, D. J. Donoghue, R. A. Moorehead, and L. A. Porter The Spy1/RINGO Family Represents a Novel Mechanism Regulating Mammary Growth and Tumorigenesis Cancer Res., May 15, 2008; 68(10): 3591 - 3600. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zeng, M.-Z. Zhang, A. B. Singh, R. Zent, and R. C. Harris ErbB4 Isoforms Selectively Regulate Growth Factor induced Madin-Darby Canine Kidney Cell Tubulogenesis Mol. Biol. Cell, November 1, 2007; 18(11): 4446 - 4456. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Feng, C. I. Sartor, D. Hunter, H. Zhou, X. Yang, L. S. Caskey, R. Dy, R. S. Muraoka-Cook, and H. S. Earp III The HER4 Cytoplasmic Domain, But Not Its C Terminus, Inhibits Mammary Cell Proliferation Mol. Endocrinol., August 1, 2007; 21(8): 1861 - 1876. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Xian Roles of Epidermal Growth Factor Family in the Regulation of Postnatal Somatic Growth Endocr. Rev., May 1, 2007; 28(3): 284 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ciarloni, S. Mallepell, and C. Brisken Amphiregulin is an essential mediator of estrogen receptor {alpha} function in mammary gland development PNAS, March 27, 2007; 104(13): 5455 - 5460. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Muraoka-Cook, L. S. Caskey, M. A. Sandahl, D. M. Hunter, C. Husted, K. E. Strunk, C. I. Sartor, W. A. Rearick Jr., W. McCall, M. K. Sgagias, et al. Heregulin-Dependent Delay in Mitotic Progression Requires HER4 and BRCA1. Mol. Cell. Biol., September 1, 2006; 26(17): 6412 - 6424. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Muraoka-Cook, M. Sandahl, C. Husted, D. Hunter, L. Miraglia, S.-m. Feng, K. Elenius, and H. S. Earp III The Intracellular Domain of ErbB4 Induces Differentiation of Mammary Epithelial Cells Mol. Biol. Cell, September 1, 2006; 17(9): 4118 - 4129. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-L. Asselin-Labat, M. Shackleton, J. Stingl, F. Vaillant, N. C. Forrest, C. J. Eaves, J. E. Visvader, and G. J. Lindeman Steroid hormone receptor status of mouse mammary stem cells. J Natl Cancer Inst, July 19, 2006; 98(14): 1011 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mallepell, A.ée Krust, P. Chambon, and C. Brisken Paracrine signaling through the epithelial estrogen receptor {alpha} is required for proliferation and morphogenesis in the mammary gland PNAS, February 14, 2006; 103(7): 2196 - 2201. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Sternlicht, S. W. Sunnarborg, H. Kouros-Mehr, Y. Yu, D. C. Lee, and Z. Werb Mammary ductal morphogenesis requires paracrine activation of stromal EGFR via ADAM17-dependent shedding of epithelial amphiregulin Development, September 1, 2005; 132(17): 3923 - 3933. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Jackson-Fisher, G. Bellinger, R. Ramabhadran, J. K. Morris, K.-F. Lee, and D. F. Stern ErbB2 is required for ductal morphogenesis of the mammary gland PNAS, December 7, 2004; 101(49): 17138 - 17143. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Lee, R. S. Pearsall, S. Das, S. K. Dey, V. L. Godfrey, and D. W. Threadgill Epiregulin Is Not Essential for Development of Intestinal Tumors but Is Required for Protection from Intestinal Damage Mol. Cell. Biol., October 15, 2004; 24(20): 8907 - 8916. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Qi, P. Kashireddy, Y. T. Zhu, S. M. Rao, and Y.-J. Zhu Null Mutation of Peroxisome Proliferator-activated Receptor-interacting Protein in Mammary Glands Causes Defective Mammopoiesis J. Biol. Chem., August 6, 2004; 279(32): 33696 - 33701. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Tikhomirov and G. Carpenter Ligand-induced, p38-dependent Apoptosis in Cells Expressing High Levels of Epidermal Growth Factor Receptor and ErbB-2 J. Biol. Chem., March 26, 2004; 279(13): 12988 - 12996. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Faulds, H. Olsen, L. A. Helguero, J.-A. Gustafsson, and L.-A. Haldosen Estrogen Receptor Functional Activity Changes during Differentiation of Mammary Epithelial Cells Mol. Endocrinol., February 1, 2004; 18(2): 412 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Long, K.-U. Wagner, K. C. K. Lloyd, N. Binart, J. M. Shillingford, L. Hennighausen, and F. E. Jones Impaired differentiation and lactational failure of Erbb4-deficient mammary glands identify ERBB4 as an obligate mediator of STAT5 Development, November 1, 2003; 130(21): 5257 - 5268. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chobotova, M.-E. Muchmore, J. Carver, H.-J Yoo, S. Manek, W. J. Gullick, D. H. Barlow, and H. J. Mardon The Mitogenic Potential of Heparin-Binding Epidermal Growth Factor in the Human Endometrium Is Mediated by the Epidermal Growth Factor Receptor and Is Modulated by Tumor Necrosis Factor-{alpha} J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5769 - 5777. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. D'Cruz, S. E. Moody, S. R. Master, J. L. Hartman, E. A. Keiper, M. B. Imielinski, J. D. Cox, J. Y. Wang, S. I. Ha, B. A. Keister, et al. Persistent Parity-Induced Changes in Growth Factors, TGF-{beta}3, and Differentiation in the Rodent Mammary Gland Mol. Endocrinol., September 1, 2002; 16(9): 2034 - 2051. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Schroeder, M. C. Adriance, E. J. McConnell, M. C. Thompson, B. Pockaj, and S. J. Gendler ErbB-beta -Catenin Complexes Are Associated with Human Infiltrating Ductal Breast and Murine Mammary Tumor Virus (MMTV)-Wnt-1 and MMTV-c-Neu Transgenic Carcinomas J. Biol. Chem., June 14, 2002; 277(25): 22692 - 22698. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Motoyama, N. E. Hynes, and H. A. Lane The Efficacy of ErbB Receptor-targeted Anticancer Therapeutics Is Influenced by the Availability of Epidermal Growth Factor-related Peptides Cancer Res., June 1, 2002; 62(11): 3151 - 3158. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Horsch, M. D. Schaller, and N. E. Hynes The Protein Tyrosine Phosphatase-PEST Is Implicated in the Negative Regulation of Epidermal Growth Factor on PRL Signaling in Mammary Epithelial Cells Mol. Endocrinol., December 1, 2001; 15(12): 2182 - 2196. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O'Shea, K. Johnson, R. Clark, M. X. Sliwkowski, and S. L. Erickson Effects of in Vivo Heregulin {beta}1 Treatment in Wild-Type and ErbB Gene-Targeted Mice Depend on Receptor Levels and Pregnancy Am. J. Pathol., May 1, 2001; 158(5): 1871 - 1880. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Weinstein and P. Leder The Extracellular Region of Heregulin Is Sufficient to Promote Mammary Gland Proliferation and Tumorigenesis but not Apoptosis Cancer Res., July 1, 2000; 60(14): 3856 - 3861. [Abstract] [Full Text] |
||||
![]() |
N. V. Patel, M. J. Acarregui, J. M. Snyder, J. M. Klein, M. X. Sliwkowski, and J. A. Kern Neuregulin-1 and Human Epidermal Growth Factor Receptors 2 and 3 Play a Role in Human Lung Development In Vitro Am. J. Respir. Cell Mol. Biol., April 1, 2000; 22(4): 432 - 440. [Abstract] [Full Text] |
||||
![]() |
C. Brisken, A. Heineman, T. Chavarria, B. Elenbaas, J. Tan, S. K. Dey, J. A. McMahon, A. P. McMahon, and R. A. Weinberg Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling Genes & Dev., March 15, 2000; 14(6): 650 - 654. [Abstract] [Full Text] |
||||
![]() |
K. M. Darcy, D. Zangani, A. L. Wohlhueter, R.-Y. Huang, M. M. Vaughan, J. A. Russell, and M. M. Ip Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during Growth, Differentiation, and Apoptosis of Normal Rat Mammary Epithelial Cells J. Histochem. Cytochem., January 1, 2000; 48(1): 63 - 80. [Abstract] [Full Text] |
||||
![]() |
F. E. Jones, T. Welte, X.-Y. Fu, and D. F. Stern Erbb4 Signaling in the Mammary Gland Is Required for Lobuloalveolar Development and Stat5 Activation during Lactation J. Cell Biol., October 4, 1999; 147(1): 77 - 88. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Saxon and D. C. Lee Mutagenesis Reveals a Role for Epidermal Growth Factor Receptor Extracellular Subdomain IV in Ligand Binding J. Biol. Chem., October 1, 1999; 274(40): 28356 - 28362. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Luetteke, T. Qiu, S. Fenton, K. Troyer, R. Riedel, A Chang, and D. Lee Targeted inactivation of the EGF and amphiregulin genes reveals distinct roles for EGF receptor ligands in mouse mammary gland development Development, January 6, 1999; 126(12): 2739 - 2750. [Abstract] [PDF] |
||||
![]() |
W. Zhou and G. Carpenter Heregulin-dependent Trafficking and Cleavage of ErbB-4 J. Biol. Chem., October 27, 2000; 275(44): 34737 - 34743. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Schroeder, M. C. Thompson, M. M. Gardner, and S. J. Gendler Transgenic MUC1 Interacts with Epidermal Growth Factor Receptor and Correlates with Mitogen-activated Protein Kinase Activation in the Mouse Mammary Gland J. Biol. Chem., April 13, 2001; 276(16): 13057 - 13064. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |